| Literature DB >> 29651324 |
T Benterud1,2,3, S Manueldas1, S Rivera4, E Henckel5,6, E M Løberg3,7, S Norgren8, L O Baumbusch1, R Solberg1,2,9, O D Saugstad1,3.
Abstract
BACKGROUND: After perinatal asphyxia, the cerebellum presents more damage than previously suggested.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29651324 PMCID: PMC5831588 DOI: 10.1155/2018/5046372
Source DB: PubMed Journal: Dis Markers ISSN: 0278-0240 Impact factor: 3.434
Figure 1Experimental protocol: twenty-nine pigs were included, twelve in each intervention group and five in the sham group. BE = base excess and BP = blood pressure.
Background and physiological parameters throughout the experiment.
| Control | Hypoxia + NACA | Hypoxia + saline | |
|---|---|---|---|
| Weight (g) | 1923 (±76) | 1874 (±184) | 1924 (±124) |
| Hypoxia time (min) | 33 (±12) | 40 (±13) | 33 (±12) |
| Hb g/100 ml start | 7.7 (±1.8) | 8.0 (±1.2) | 7.0 (±1.0) |
| Hb g/100 ml end | 5.9 (±1.2) | 6.3 (±0.8) | 7.1 (±2.7) |
| Gender (male/female) | 3/2 | 6/6 | 6/6 |
| pH | |||
| Start | 7.44 (±0.04) | 7.42 (±0.04) | 7.45 (±0.04) |
| End hypoxia | 7.43 (±0.05) | 6.87 (±0.08) | 6.92 (±0.11) |
| 30 min reox | 7.46 (±0.04) | 7.18 (±0.09) | 7.18 (±0.07) |
| 90 min reox | 7.45 (±0.06) | 7.45 (±0.04) | 7.35 (±0.08) |
| 270 min reox | 7.42 (±0.12) | 7.45 (±0.04) | 7.39 (±0.10) |
| 570 min reox | 7.38 (±0.06) | 7.42 (±0.04) | 7.39 (±0.09) |
| BE (mmol/l) | |||
| Start | 4.3 (±2.9) | −0.5 (±4.9) | −0.3 (±3.6) |
| End hypoxia | 4.1 (±3.6) | −18.9 (±2.2) | −19.0 (±3.9) |
| 30 min reox | 4.4 (±1.9) | −13.3 (±4.7) | −15.1 (±3.5) |
| 90 min reox | 4.2 (±2.3) | −3.9 (±5.0) | −5.7 (±4.6) |
| 270 min reox | 2.9 (±4.5) | −2.2 (±4.4) | −1.4 (±5.0) |
| 570 min reox | 0.5 (±3.4) | −6.5 (±6.6) | −3.7 (±5.4) |
| Lactate (mmol/l) | |||
| Start | 2.3 (±1.1) | 2.3 (±1.1) | 2.8 (±1.0) |
| End hypoxia | 2.4 (±2.1) | 14.3 (±2.7) | 13.2 (±3.1) |
| 30 min reox | 1.8 (±1.1) | 10.7 (±3.8) | 11.2 (±0.6) |
| 90 min reox | 1.5 (±0.6) | 5.9 (±2.2) | 6.3 (±2.1) |
| 270 min reox | 1.3 (±0.4) | 1.7 (±0.8) | 2.3 (±2.2) |
| 570 min reox | 1.7 (±1.0) | 1.4 (±1.0) | 2.1 (±2.0) |
| Glucose (mmol/l) | |||
| Start | 5.0 (±1.2) | 6.4 (±2.1) | 6.7 (±2.3) |
| End hypoxia | 5.0 (±1.5) | 9.6 (±3.4) | 9.1 (±3.7) |
| 30 min reox | 4.7 (±0.8) | 8.0 (±3.5) | 7.5 (±3.6) |
| 90 min reox | 4.9 (±0.6) | 6.5 (±2.3) | 6.7 (±2.3) |
| pCO2 (kPa) | |||
| Start | 5.0 (±1.1) | 5.2 (±0.9) | 5.0 (±1.1) |
| End hypoxia | 5.7 (±0.3) | 8.4 (±1.4) | 7.7 (±1.1) |
| 30 min reox | 5.4 (±0.6) | 5.1 (±0.8) | 4.4 (±0.6) |
Figure 2In situ zymography of the cerebellum. Net in situ gelatinolytic activity increases in the nucleus of Purkinje cells in the cerebellum after hypoxia-resuscitation. Fluorescence photomicrographs of cerebellar sections displaying in situ zymography in pigs who were sham-operated, exposed to NACA after hypoxia, and vehicle-treated groups. Intranuclear fluorescence signal in Purkinje cells (white arrow) represents the proteolytic activity (green). An increase in fluorescence signal strength represents a higher degree of proteolytic activity. The graph represents the quantification of net gelatinolytic activity (in arbitrary units (AU) of fluorescence) for sham 52 (±12), NACA group 72 (±16), and vehicle-treated group 97 (±36). Values are given as mean ± SD. Hoechst dye was used as a nuclear marker (blue). Images are representative of pictures obtained from each group.
| Generalized damage | Localized or no damage | Total | |
|---|---|---|---|
| Intervention | 9 | 9 | 18 |
| Sham | 0 | 5 | 5 |
| Total | 9 | 14 | 23 |
Figure 3An example of localized damage in the cerebellum from one pig (two different magnifications 100x and 400x). In (b), the red arrows point to eosinophilic Purkinje cells, representing neurons with hypoxic injury. The black arrows point to normal Purkinje cells.
Figure 4The picture depicts mtDNA mutations in the cerebellum. Values are given as mean ± SD. When comparing the ratios of mutations between the different groups, there was a significantly lower ratio of mutations in pigs exposed to NACA after severe hypoxia than in vehicle-treated group (2.0 × 10−4, SD ± 2.0 × 10−4 versus 4.9 × 10−4, SD ± 3.6 × 10−4), p < 0.05.